Apolipoprotein A-I deficiency does not affect biliary lipid secretion and gallstone formation in mice

Liver International

Volumn 31, Issue 2, 2011, Pages 263-271

  Amigo, Ludwig ^a   Quiñones, Verónica ^a   Leiva, Andrea ^a   Busso, Dolores ^a   Zanlungo, Silvana ^a   Nervi, Flavio ^a   Rigotti, Attilio ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Apo A I; Biliary lipids; Gallstones; HDL; Mice; Plasma cholesterol

Indexed keywords

APOLIPOPROTEIN A1; BILE ACID; LIPID;

ARTICLE; BILIARY LIPID SECRETION; CHOLELITHIASIS; CHOLESTASIS; CHOLESTEROL DIET; CHOLESTEROL INTAKE; CHOLESTEROL STONE; CONTROLLED STUDY; FEEDING; GALLSTONE FORMATION; HOMEOSTASIS; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; PRECIPITATION; PROTEIN EXPRESSION; WILD ANIMAL;

ANIMALS; APOLIPOPROTEIN A-I; BILE ACIDS AND SALTS; CHOLESTEROL, HDL; DIET, ATHEROGENIC; FECES; GALLSTONES; MICE; MICE, KNOCKOUT; RNA, MESSENGER;

EID: 78650784977     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2010.02421.x     Document Type: Article

References (43)

1. Lewis GF, Rader DJ. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 2005; 96: 1221-32.
2. Spady DK, Woollett LA, Meidell RS, Hobbs HH. Kinetic characteristics and regulation of HDL cholesteryl ester and apolipoprotein transport in the apoA-I-/- mouse. J Lipid Res 1998; 39: 1483-92.
3. Woollett LA, Kearney DM, Spady DK. Diet modification alters plasma HDL cholesterol concentrations but not the transport of HDL cholesteryl esters to the liver in the hamster. J Lipid Res 1997; 38: 2289-302.
4. Woollett LA, Spady DK. Kinetic parameters for high density lipoprotein apoprotein AI and cholesteryl ester transport in the hamster. J Clin Invest 1997; 99: 1704-13.
5. Bothman KM, Bravo E. The role of lipoprotein cholesterol in biliary steroid secretion. Studies with in vivo experimental models. Prog Lipid Res 1995; 34: 71-97.
6. Plump AS, Azrolan N, Odaka H, et al. ApoA-I knockout mice: characterization of HDL metabolism in homozygotes and identification of a post-RNA mechanism of apoA-I up-regulation in heterozygotes. J Lipid Res 1997; 38: 1033-47.
7. Rubin EM, Ishida BY, Clift SM, Krauss RM. Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses. Proc Natl Acad Sci USA 1991; 88: 434-8.
8. Williamson R, Lee D, Hagaman J, Maeda N. Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I. Proc Natl Acad Sci USA 1992; 89: 7134-8.
9. Jolley CD, Woollett LA, Turley SD, Dietschy JM. Centripetal cholesterol flux to the liver is dictated by events in the peripheral organs and not by the plasma high density lipoprotein or apolipoprotein A-I concentration. J Lipid Res 1998; 39: 2143-9.
10. Jolley CD, Dietschy JM, Turley SD. Induction of bile acid synthesis by cholesterol and cholestyramine feeding is unimpaired in mice deficient in apolipoprotein AI. Hepatology 2000; 32: 1309-16.
11. Thronton JR, Heaton KW, MacFarlane DG. A relation between high-density-lipoprotein cholesterol and bile saturation. Br Med J 1981; 283: 1352-4.
12. Miquel JF, Covarrubias C, Villaroel L, et al. Genetic epidemiology of cholesterol cholelithiasis among chilean hispanics, amerindians, and maoris. Gastroenterology 1998; 115: 937-46.
13. Petitti DB, Friedman GD, Klatsky AL. Association of a history of gallstone disease with a reduced concentration of high density lipoprotein cholesterol. N Engl J Med 1981; 304: 1396-8.
14. Thijs C, Knipschild P, Brombacher P. Serum lipids and gallstones: a case-control study. Gastroenterology 1990; 99: 843-9.
15. Khanuja B, Cheah YC, Hunt M, et al. Lith1, a major gene affecting cholesterol gallstone formation among inbred strains of mice. Proc Natl Acad Sci USA 1995; 92: 7729-33.
16. Groen AK, Bloks VW, Bandsma RH, et al. Hepatobiliary cholesterol transport is not impaired in abca1-null mice lacking HDL. J Clin Invest 2001; 108: 843-50.
17. Kawamoto T, Mao SJ, LaRusso NF. Biliary excretion of apolipoprotein B by the isolated perfused rat liver. Relationship to receptor-mediated uptake of human low-density lipoprotein and biliary lipid secretion. Gastroenterology 1987; 92: 1236-42.
18. Ohisalo JJ, Keso L, Ehnholm C. Apolipoproteins AI and AII in human bile. Acta Physiol Scand 1983; 119: 303-4.
19. Sewell RB, Mao SJ, Kawamoto T, LaRusso NF. Apolipoproteins of high, low, and very low density lipoproteins in human bile. J Lipid Res 1983; 24: 391-40.
20. Secknus R, Darby GH, Chernosky A, et al. Apolipoprotein A-I in bile inhibits cholesterol crystallization and modifies transcellular lipid transfer through cultured human gall-bladder epithelial cells. J Gastroenterol Hepatol 1999; 14: 446-56.
21. Kibe A, Holzbach RT, LaRusso NF, Mao SJ. Inhibition of cholesterol crystal formation by apolipoproteins in supersaturated model bile. Science 1984; 225: 514-6.
22. Tao S, Tazuma S, Kajiyama G. Apolipoprotein A-I stabilizes phospholipid lamellae and thus prolongs nucleation time in model bile systems: an ultrastructural study. Biochim Biophys Acta 1993; 1166: 25-30.
23. Amigo L, Mardones P, Ferrada C, et al. Biliary lipid secretion, bile acid metabolism, and gallstone formation are not impaired in hepatic lipase-deficient mice. Hepatology 2003; 38: 726-34.
24. Amigo L, Mendoza H, Castro J, et al. Relevence of niemann-pick type C1 protein expression in controlling plasma cholesterol and biliary lipid secretion in mice. Hepatology 2002; 36: 819-28.
25. Mardones P, Quinones V, Amigo L, et al. Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type I-deficient mice. J Lipid Res 2001; 42: 170-80.
26. Rigotti A, Trigatti BL, Penman M, et al. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci USA 1997; 94: 12610-5.
27. Amigo L, Quinones V, Mardones P, et al. Impaired biliary cholesterol secretion and decreased gallstone formation in apolipoprotein E-deficient mice fed a high-cholesterol diet. Gastroenterology 2000; 118: 772-9.
28. Nervi F, Marinovic I, Rigotti A, Ulloa N. Regulation of biliary cholesterol secretion. Functional relationship between the canalicular and sinusoidal cholesterol secretory pathways in the rat. J Clin Invest 1988; 82: 1818-25.
29. Turley SD, Dietschy JM. Re-evaluation of the 3 alpha-hydroxysteroid dehydrogenase assay for total bile acids in bile. J Lipid Res 1978; 19: 924-48.
30. Baginski ES, Fos PP, Zak B. Microdetermination of inorganic phosphate, phospholipids, and total phosphate in biological material. Clin Chem 1967; 13: 326-32.
31. Wang DQ, Paigen B, Carey MC. Phenotypic characterization of lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: physical-chemistry of gallbladder bile. J Lipid Res 1997; 38: 1395-411.
32. Turley S, Dietschy JM. The metabolism and excretion of cholesterol by the liver. In: Arias IM, Jakoby W, Popper H, Schachter D, Shafritz DA, eds. The Liver: Biology and Pathobiology. New York, NY: Raven Press, 1998; 617-41.
33. Wang HH, Wang DQ. Reduced susceptibility to cholesterol gallstone formation in mice that do not produce apolipoprotein B48 in the intestine. Hepatology 2005; 42: 894-904.
34. Hughes SD, Verstuyft J, Rubin EM. HDL deficiency in genetically engineered mice requires elevated LDL to accelerate atherogenesis. Arterioscler Thromb Vasc Biol 1997; 17: 1725-9.
35. Iqbal J, Hussain MM. Evidence for multiple complementary pathways for efficient cholesterol absorption in mice. J Lipid Res 2005; 46: 1491-501.
36. Welty FK, Lichtenstein AH, Barrett PH, et al. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes. Arterioscler Thromb Vasc Biol 2004; 24: 1703-7.
37. Alam K, Meidell RS, Spady DK. Effect of up-regulating individual steps in the reverse cholesterol transport pathway on reverse cholesterol transport in normolipidemic mice. J Biol Chem 2001; 276: 15641-9.
38. Eriksson M, Carlson LA, Miettinen TA, Angelin B. Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans. Circulation 1999; 100: 594-8.
39. Nanjee MN, Cooke CJ, Garvin R, et al. Intravenous apoA-I/lecithin discs increase pre-beta-HDL concentration in tissue fluid and stimulate reverse cholesterol transport in humans. J Lipid Res 2001; 42: 1586-93.
40. Osono Y, Woollett LA, Marotti KR, et al. Centripetal cholesterol flux from extrahepatic organs to the liver is independent of the concentration of high density lipoprotein-cholesterol in plasma. Proc Natl Acad Sci USA 1996; 93: 4114-9.
41. Tall AR, Wang N, Mucksavage P. Is it time to modify the reverse cholesterol transport model. J Clin Invest 2001; 108: 1273-5.
42. van der Velde AE, Groen AK. Shifting gears: liver SR-BI drives reverse cholesterol transport in macrophages. J Clin Invest 2005; 115: 2699-701.
43. Kruit JK, Plosch T, Havinga R, et al. Increased fecal neutral sterol loss upon liver X receptor activation is independent of biliary sterol secretion in mice. Gastroenterology 2005; 128: 147-56.